MAPK14 and chronic obstructive pulmonary disease: The application of a p38 inhibitor can restore GC sensitivity and has been shown in peripheral blood mononuclear and bronchial epithelial cells derived from patients with severe asthma and chronic obstructive pulmonary disease (COPD) [38,39,64].